Literature DB >> 4740209

[NMR studies on the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation].

H Fenner, G Mixich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4740209

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  5 in total

Review 1.  The amphiprotic character of azapropazone and its relevance to the gastric mucosa.

Authors:  K McCormack; K Brune
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved.

Authors:  W S Beck; H T Schneider; K Dietzel; B Nuernberg; K Brune
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Excretion of azapropazone in human breast milk.

Authors:  R Bald; E M Bernbeck-Betthäuser; H Spahn; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Plasma protein binding of azapropazone in patients with kidney and liver disease.

Authors:  E Jähnchen; K J Blanck; K H Breuing; H J Gilfrich; T Meinertz; D Trenk
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 5.  Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs.

Authors:  K McCormack; K Brune
Journal:  Arch Toxicol       Date:  1987-06       Impact factor: 5.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.